David Bednar

Title: David Bednar - Innovator in Thermostable Polypeptides

Introduction

David Bednar is a notable inventor based in Brno, Czech Republic. He has made significant contributions to the field of cell biology and regenerative medicine through his innovative research and patents. His work focuses on the development of thermostable polypeptides, which have important applications in various medical and cosmetic fields.

Latest Patents

David Bednar holds a patent for a thermostable FGF2 polypeptide, which is an isolated polypeptide possessing FGF2 activity. This polypeptide has at least 85% sequence identity to SEQ ID NO: 2 (FGF2 wt) or a functional fragment thereof. It includes at least one amino acid substitution, specifically R31L, and is utilized in cell biology research, regenerative medicine, and related medical applications or cosmetics. Additionally, his invention discloses a culture medium comprising subjected FGF2, which is suitable for culturing human pluripotent stem cells, including both human embryonic stem cells and induced pluripotent stem cells.

Career Highlights

Throughout his career, David Bednar has worked with esteemed institutions such as Masaryk University and Enantis s.r.o. His experience in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

David has collaborated with notable colleagues, including Jan Brezovsky and Pavel Dvorak. These partnerships have further enriched his research endeavors and have led to advancements in the field of biotechnology.

Conclusion

David Bednar is a prominent inventor whose work on thermostable polypeptides has the potential to impact various fields, including medicine and cosmetics. His innovative contributions continue to shape the landscape of cell biology research.